Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
pharmacy benefit management for decades
Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity
No GLP-1 receptor agonist is approved to treat inflammatory bowel disease
Patchie GLP-1 Patches deliver active ingredients through your skin using a transdermal system
EU-Versand: Versand aus dem EU-Lager
US$ 20.42
US$ 22.94
US$ 28.79
US$ 23.83
